NCT07179211Active, not recruiting
Peripheral Artery Disease in Regular Hemodialysis Patients
Relation Between Neutrophil to Lymphocyte Ratio and Peripheral Artery Disease in Regular Hemodialysis Patients at Sohag University Hospital
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
Recent studies have reinforced the association between high NLR and PAD in hemodialysis patients. This highlights the need for further studies to confirm its predictive value and determine optimal cut-off thresholds tailored to local patient populations. Accordingly, the present study aims to investigate the relationship between NLR and the presence of PAD in patients undergoing regular hemodialysis. By establishing this association in a well-defined population, we hope to provide evidence that supports the use of NLR as a simple, cost-effective tool for PAD risk stratification and early intervention
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 2 Sept 2025
- Start date
- 13 Jul 2025
- Primary completion date
- 13 Jan 2026
- Lead sponsor
- Sohag University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07179211
What you commit to
- Study type: Observational
- Planned participants: 120
- From 13 Jul 2025 to the primary completion date, 13 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current use of immunosuppressive therapy, corticosteroids, or chemotherapy.5. History of malignancy.6. Patients with incomplete medical records or unable to undergo peripheral vascular assessment.
Lab values
- Active infection or sepsis at the time of evaluation
- .\* Patients who have a sedimentation rate of more than 60 mm/hour
- \*. Known autoimmune or hematologic disorders that may influence leukocyte count.
Who the study is looking for
- Adult patients aged ≥18 years.
- Undergoing maintenance hemodialysis for at least 3 months (thrice weekly)
- Able to provide informed consent.
- Willing to undergo clinical and laboratory evaluations, including peripheral vascular assesment
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag faculty Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.